Merit Medical Systems INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Merit Medical Systems, Inc. announced record-setting 2025 revenue of $1.516 billion, strong profitability, and a successful CEO transition to Martha G. Aronson, alongside proposals for its 2026 Annual Meeting.
NASDAQ
Merit Medical Systems, Inc. announces its 2025 Annual Meeting of Shareholders to be held virtually on May 14, 2025, with key proposals including the election of directors and ratification of the company's executive compensation and auditor appointment.
NASDAQ
Merit Medical Systems announces its 2025 Annual Meeting of Shareholders to be held virtually on May 14, 2025, following a year of strong financial results and strategic advancements.
NASDAQ
DEFA14A: Merit Medical Systems, Inc. Sets Date for Annual Shareholder Meeting, Outlines Key Proposals
Merit Medical Systems, Inc. announces its annual shareholder meeting to be held on May 15, 2024, outlining proposals for director elections, executive compensation, an incentive plan amendment, and auditor ratification.
NASDAQ
Merit Medical Systems is soliciting proxies for its upcoming annual meeting, featuring proposals for director elections, executive compensation, and an increase in shares authorized under its long-term incentive plan.